Brett Winton

1 month ago | ark-invest.com | Nemo focuses |Nemo Marjanovic |Brett Winton

In this episode of FYI - For Your Innovation, ARK’s Chief Futurist, Brett Winton, and Research Analyst Nemo Marjanovic, sit down with Dr. Jin Hyung Lee, a leading neuroscience researcher at Stanford University. Dr. Lee and her team are pioneering breakthroughs in understanding brain function—an essential step toward diagnosing and treating neurological disorders.

1 month ago | ark-invest.com | Lorenzo focuses |Lorenzo Valente |Brett Winton

Why Alchemy is the AWS for blockchain—and what that means for crypto’s evolutionSmart contracts as a better alternative to traditional financial intermediariesMapping value accrual in smart contract platforms: A $5T opportunity by 2030How Alchemy abstracts blockchain complexity and improves developer UXWhy blockchain is still in its “green screen” era—and what comes nextMeme coins, signal or noise? Nikil’s take on speculation vs.

2 months ago | trustnet.com | Brett Winton

Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness.

Mar 23, 2025 | ark-invest.com | Tasha Keeney |Daniel C. Maguire |Frank Downing |Brett Winton

Last week, Google announced the sixth-largest US tech merger and acquisition (M&A) transaction in history—and the largest in its own corporate history—when it acquired Wiz, a private cybersecurity company, for $32 billion in cash.13 The transaction follows a severely restrained M&A environment driven largely by restrictions imposed by the Federal Trade Commission (FTC).

Mar 20, 2025 | ark-invest.com | Charles Roberts |Brett Winton

In this episode of For Your Innovation, the ARK team is joined by Umoja’s CEO, Dr. Andy Scharenberg, and CFO, Britton Russell, to discuss their journey, vision, and the innovative science reshaping cancer treatment. Dr. Scharenberg explains how Umoja’s in vivo gene delivery platform, VivoVec, represents a third-generation leap in CAR T-cell therapies—offering the potential to make cutting-edge treatments more scalable, accessible, and cost-effective.